関連する実験動画
Updated: Apr 13, 2026

11:13
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
8.7K
素粒子の迅速かつ長期的動員および増殖のための双特定抗体の合理的な設計
Jia Deng1, Yan Liu2, Yuhan Zhang2
1School of Chemistry and Chemical Engineering, State Key Laboratory of Coordination Chemistry, Nanjing University, 163 Xianlin Road, Qixia District, Nanjing, Jiangsu 210093, China.
International immunopharmacology
|September 3, 2025
まとめ
粒細胞コロニー刺激因子受容体 (G- CSFR) とC- X- Cケモカイン受容体4 (CXCR4) を標的とする新型双特定抗体は,中性粒子の数を効果的に増加させる. この合成抗体は ニュートロペニアの新治療法として有望です
科学分野:
- 免疫学
- バイオテクノロジー
- 薬理学について
背景:
- 粒細胞コロニー刺激因子 (G-CSF) とC-X-Cケモカイン受容体4 (CXCR4) / ストロマル細胞由来因子-1 (SDF-1) 軸は中性粒子の調節に不可欠である.
- 二固有の抗体は,半減期を延長した複数の受容体を同時に標的にすることで治療的アプローチを提供します.
研究 の 目的:
- G-CSFアゴニズムとCXCR4アンタゴニズムを組み合わせたバイスペシフィック抗体を設計する.
- 中性粒子の数を増加させるこの双特定抗体の有効性を評価する.
主な方法:
- ヒトのG-CSFと抗CXCR4ペプチドをハーセプチンのCDR3領域に埋め込み,双固有の抗体を設計した.
- 中性粒子の動員のための抗体の in vitro と in vivo の活動を評価した.
主要な成果:
- 二固有の抗体は,中性粒子の数値の急速かつ持続的な増加を示した.
- 中性粒子を増加させる効果は,G-CSFとCXCR4を標的とした治療の組み合わせを上回った.
- 抗体はG-CSFの刺激とCXCR4の抑制効果を相乗せました.
結論:
- 遺伝子組み換えバイスペシフィック抗体は ニュートロペニアの強力な治療候補です
- CDR移植戦略は,アゴニスティックとアンタゴニスティック機能を併用したバイスペシフィック抗体を開発するための汎用性のあるプラットフォームです.
関連する概念動画
Antibody Structure
68.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
68.8K
Cross-reactivity
34.0K
Overview
34.0K
Antigens Involved in Adaptive Immunity
1.9K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.9K
Diversity of Antigen Receptors
2.2K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
2.2K
B Cell Activation and Differentiation
18.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.6K
Antibody Structure and Classes
10.4K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
10.4K

